Your browser doesn't support javascript.
loading
Sexual risk behaviors and STDs among persons who inject drugs: A national study.
Brookmeyer, Kathryn A; Haderxhanaj, Laura T; Hogben, Matthew; Leichliter, Jami.
Afiliação
  • Brookmeyer KA; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, United States of America. Electronic address: Kbrookmeyer@cdc.gov.
  • Haderxhanaj LT; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, United States of America.
  • Hogben M; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, United States of America.
  • Leichliter J; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, United States of America.
Prev Med ; 126: 105779, 2019 09.
Article em En | MEDLINE | ID: mdl-31319117
ABSTRACT
Opioid use and the rising case reports of STDs represent co-occurring epidemics; research indicates that persons who inject drugs (PWID) may be at increased risk for acquiring STDs. We use the National Survey of Family Growth (NSFG, 2011-2015) to examine the prevalence of risky sexual behaviors and STD diagnoses among PWID. We describe demographic characteristics, sexual behaviors, and self-reported STD diagnoses of sexually active women and men, separately, by whether they had ever engaged in injection-related behaviors (age 15-44; N = 9006 women, N = 7210 men). Results indicate that in 2011-15, 1.4% of women and 2.6% of men reported ever engaging in injection-related behaviors. Examining the full logistic regression models indicate that for women, sex with a PWID in the past 12 months (AOR = 5.8, 95% CI 2.9, 11.7), exchanging money/drugs for sex in the past 12 months (AOR = 3.6, 95% CI 1.2, 10.9), chlamydia and/or gonorrhea diagnosis in the past 12 months (AOR = 2.6, 95% CI 1.2, 5.3), ever having a syphilis diagnosis (AOR = 8.5, 95% CI 3.1, 23.4), and ever having a herpes diagnosis (AOR = 3.3, 95% CI 1.0, 10.3) were associated with increased odds of engaging in injection-related behaviors. For men, sex with a PWID in the past 12 months (AOR = 10.9, 95% CI 4.3, 27.7), ever being diagnosed with syphilis (AOR = 5.8, 95% CI 1.8, 18.0), and ever being diagnosed with herpes (AOR = 2.7, 95% CI 1.0, 7.1) were significantly associated with increased odds of engaging in injection-related behaviors. Future research may examine critical intervention points, including co-occurring factors in both STD acquisition and injection drug use.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Infecções Sexualmente Transmissíveis / Abuso de Substâncias por Via Intravenosa / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Infecções Sexualmente Transmissíveis / Abuso de Substâncias por Via Intravenosa / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2019 Tipo de documento: Article